IL174770A0 - Anti-insulin-like growth factor-i-receptor antibodies - Google Patents
Anti-insulin-like growth factor-i-receptor antibodiesInfo
- Publication number
- IL174770A0 IL174770A0 IL174770A IL17477006A IL174770A0 IL 174770 A0 IL174770 A0 IL 174770A0 IL 174770 A IL174770 A IL 174770A IL 17477006 A IL17477006 A IL 17477006A IL 174770 A0 IL174770 A0 IL 174770A0
- Authority
- IL
- Israel
- Prior art keywords
- insulin
- growth factor
- receptor antibodies
- antibodies
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/729,441 US8034904B2 (en) | 2002-06-14 | 2003-12-08 | Anti-IGF-I receptor antibody |
PCT/US2004/038230 WO2005061541A1 (en) | 2002-06-14 | 2004-12-07 | Anti-igf-i receptor antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
IL174770A0 true IL174770A0 (en) | 2006-08-20 |
Family
ID=36616549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL174770A IL174770A0 (en) | 2003-12-08 | 2006-04-04 | Anti-insulin-like growth factor-i-receptor antibodies |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1692176A4 (en) |
JP (1) | JP2008502589A (en) |
KR (1) | KR20070001883A (en) |
CN (1) | CN1886424A (en) |
AU (1) | AU2004303792A1 (en) |
BR (1) | BRPI0417406A (en) |
CA (1) | CA2548065A1 (en) |
CR (1) | CR8426A (en) |
EA (1) | EA009807B1 (en) |
EC (1) | ECSP066595A (en) |
IL (1) | IL174770A0 (en) |
MX (1) | MXPA06005540A (en) |
NO (1) | NO20063155L (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2010339770B2 (en) | 2009-12-21 | 2015-02-12 | Genentech, Inc. | Antibody formulation |
KR20130065665A (en) * | 2010-05-11 | 2013-06-19 | 아베오 파마슈티컬즈, 인크. | Anti-fgfr2 antibodies |
EP2766478A4 (en) * | 2011-10-10 | 2015-06-17 | Los Angeles Childrens Hospital | Novel asparaginase and methods for treating diseases associated with asparagine dependence |
CN103509117B (en) * | 2013-05-06 | 2016-03-09 | 江苏匡亚生物医药科技有限公司 | Bi-specific antibody of anti-human HER2 and people IGF-IR and its production and use |
KR20230170992A (en) * | 2017-05-30 | 2023-12-19 | 데이진 화-마 가부시키가이샤 | Anti-igf-i receptor antibody |
CN118615438A (en) * | 2023-03-07 | 2024-09-10 | 康方药业有限公司 | Pharmaceutical combination comprising anti-CTLA 4-anti-PD-1 bispecific antibodies and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002532685A (en) * | 1998-12-04 | 2002-10-02 | ノバルティス アクチエンゲゼルシャフト | Methods and compositions useful for targeting activated vitronectin receptor αVβ3 |
AP2072A (en) * | 2001-01-05 | 2009-12-10 | Pfizer | Antibodies to insulin-like growth factor I receptor |
US7538195B2 (en) * | 2002-06-14 | 2009-05-26 | Immunogen Inc. | Anti-IGF-I receptor antibody |
KR20070086866A (en) * | 2003-02-13 | 2007-08-27 | 화이자 프로덕츠 인크. | Uses of anti-insulin-like growth factor ⅰ receptor antibodies |
-
2004
- 2004-12-07 BR BRPI0417406-2A patent/BRPI0417406A/en not_active IP Right Cessation
- 2004-12-07 CA CA002548065A patent/CA2548065A1/en not_active Abandoned
- 2004-12-07 CN CNA200480034889XA patent/CN1886424A/en active Pending
- 2004-12-07 EP EP04811082A patent/EP1692176A4/en not_active Ceased
- 2004-12-07 JP JP2006543832A patent/JP2008502589A/en active Pending
- 2004-12-07 KR KR1020067010010A patent/KR20070001883A/en not_active Application Discontinuation
- 2004-12-07 EA EA200600931A patent/EA009807B1/en not_active IP Right Cessation
- 2004-12-07 AU AU2004303792A patent/AU2004303792A1/en not_active Abandoned
- 2004-12-07 MX MXPA06005540A patent/MXPA06005540A/en active IP Right Grant
-
2006
- 2006-04-04 IL IL174770A patent/IL174770A0/en unknown
- 2006-05-31 EC EC2006006595A patent/ECSP066595A/en unknown
- 2006-06-01 CR CR8426A patent/CR8426A/en not_active Application Discontinuation
- 2006-07-07 NO NO20063155A patent/NO20063155L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1692176A1 (en) | 2006-08-23 |
CR8426A (en) | 2007-12-04 |
JP2008502589A (en) | 2008-01-31 |
CA2548065A1 (en) | 2005-07-07 |
MXPA06005540A (en) | 2006-08-17 |
ECSP066595A (en) | 2006-10-17 |
CN1886424A (en) | 2006-12-27 |
BRPI0417406A (en) | 2007-04-03 |
EP1692176A4 (en) | 2008-11-12 |
AU2004303792A1 (en) | 2005-07-07 |
NO20063155L (en) | 2006-08-11 |
KR20070001883A (en) | 2007-01-04 |
EA009807B1 (en) | 2008-04-28 |
EA200600931A1 (en) | 2006-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL243914A0 (en) | Anti-vegf antibodies | |
IL169690A0 (en) | Uses of anti-insulin-like growth factor i receptor antibodies | |
EP1616881A4 (en) | Anti-mpl antibodies | |
IL175608A0 (en) | Antibodies | |
IL173557A0 (en) | Variable antibodies | |
IL202681A0 (en) | Interleukin-10 antibodies | |
EP1494693A4 (en) | Cripto-specific antibodies | |
IL174770A0 (en) | Anti-insulin-like growth factor-i-receptor antibodies | |
EP1598368A4 (en) | Anti-pci neutralizing antibodies | |
AU2003221663A1 (en) | Hair growth | |
HU0300097V0 (en) | Slotmachine for flower | |
IL172511A0 (en) | Specific human antibodies | |
EP1646078A4 (en) | Epitaxial growth process | |
GB0322082D0 (en) | Growth can | |
AP2740A (en) | Anti-VEGF antibodies | |
EP1641929A4 (en) | Floral transformation | |
GB0317974D0 (en) | Novel antibodies | |
GB0329711D0 (en) | Antibodies | |
AU2003901902A0 (en) | Improved planter point | |
GB0326734D0 (en) | Growth method | |
GB0319345D0 (en) | Variable antibodies | |
GB0319118D0 (en) | Variable antibodies | |
AU2003906592A0 (en) | Ligature carrier | |
AU2004901747A0 (en) | Novel growth factor | |
AU2003906928A0 (en) | Cyclospora Antibodies |